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Simple Summary: Families with an inherited high risk of bowel cancer may struggle to share
information about their diagnosis. This means that relatives are not always aware of their increased
risk of cancer or able to access screening for the early detection of cancer. Through this study, we
aimed to help such families by creating a website where patients could share confidential information
with their relatives securely online. Following a survey and telephone interviews with affected
individuals, the content of the website was developed to suit the needs of families. Website function
was tested with patients to check feasibility and acceptability. Most participants wanted more
information to support their adaptation to the diagnosis and help inform their relatives. This study
demonstrates how health professionals can improve access to genetic testing and cancer screening in
families at high risk of cancer, thus reducing morbidity and mortality.
Abstract: Individuals with pathogenic variants in genes predisposing to bowel cancer are encour-
aged to share this information within their families. Close relatives at 50% risk can have access to
bowel cancer surveillance. However, many relatives remain unaware of their vulnerability or have
insufficient information. We investigated the feasibility and acceptability of using a secure website to
support information sharing within families at high risk of bowel cancer. Patients (n = 286) answered
an anonymous cross-sectional survey, with 14 participating in telephone interviews. They reported
that the diagnosis had a profound effect on them and their family relationships, and consequently
desired more support from health professionals. Website content was created in response to the
preferences of survey and interview participants. Reactions to the website from 12 volunteers were
captured through remote usability testing to guide further refinement of the website. Participants
welcomed the opportunity to store and share personal information via the website and wanted more
information and help informing their relatives about the diagnosis. Important website topics were:
healthy lifestyle; genetic testing; and how to talk to children about the diagnosis. A website providing
online access to confidential documents was both feasible and acceptable and could translate into
increased uptake of cancer surveillance, resulting in lower morbidity and mortality in these families.
Keywords: bowel cancer; genetic testing; familial cancer; relatives; website; information sharing;
genetic diagnosis; communication; cancer surveillance; Lynch syndrome
1. Introduction
An inherited vulnerability to cancer affects many people worldwide [1,2]. Typically,
syndromes that confer a high risk of specific tumours are inherited in an autosomal
dominant manner, where the first degree relatives of someone with a pathogenic variant
are at 50% risk of having the same genetic variant [1]. Identifying those at risk and
enabling them to access appropriate diagnostic screening (such as colonoscopy) is an
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effective strategy to reduce morbidity and mortality [3,4]. Consequently, it is important
to investigate and then implement interventions that can facilitate cancer predisposition
cascade testing and cancer surveillance [5]. Relatives at risk of cancer first need to be aware
of the familial diagnosis, then understand the implications of that for themselves and have
the ability to access testing and surveillance. Access may be facilitated by documentary
evidence of risk; therefore, we sought to make an intervention that could address those
factors: awareness, understanding and evidence of risk.
Screening for colorectal cancer in high risk individuals is an example of personalised
preventative medicine. Whilst screening by colonoscopy can benefit the individual by
reducing their risk of invasive cancer [3,6], personal choice is not possible until someone
is informed of the options available to them. It has been demonstrated that the uptake
of genetic testing and subsequent cancer screening is influenced by many factors, both
organisational and personal. Disease registries can help organise screening for patients that
are known to them [5,7,8] and specialist clinics can provide coordinated advice and screen-
ing, but clinical guidelines are not always applied in practice [9,10]. Evidence suggests
that genetic testing in relatives at risk of bowel cancer is suboptimal [5,11,12]. This causes
real concern on several levels: those at risk may not be receiving appropriate surveillance
and treatment; conversely, those relatives who have not inherited the vulnerability may
be having unnecessary colonoscopy, and calculations of cost-effectiveness for testing in
bowel and endometrial cancers (which are guiding health policy in the UK and Australia)
would be undermined [13,14]. The relatively low uptake of genetic testing may in part be
due to family members not wishing to have genetic testing [15], but contributing factors
could be the limited information provided for relatives in clinical practice [16], the cost of
testing [17], the absence of coordinated care and uncertainty in affected relatives [18].
Several groups have sought to develop interventions to improve communication
in families to improve awareness and appreciation of cancer risk [19]. These studies
have taken place across different health systems (in the UK, Europe, Australia and the
USA) [20–31], but common to all of them is the premise that patients could benefit from
guidance about how to approach their relatives and explain to them about the diagnosis.
In addition, it has been suggested that patients benefit from receiving information that
is written for them or tailored to their specific needs [27,32,33]. In the USA, a website
(https://kintalk.org/) (accessed on 27 February 2021) was created in order to encourage
and support people with Lynch syndrome or HBOC to share information about the diagno-
sis with their relatives. This website has the strapline “empowering families through commu-
nication and education” and provides a secure document sharing function that we wished
to emulate. Although the Kintalk website has been cited on several occasions [34–37], we
could find no published evidence of its efficacy or acceptability with users at the time of
our study. We were also mindful that the experiences of patients in the USA could be
substantially different to that of patients in other countries due to the differences in the
delivery of healthcare [38]. For example, the cost implications of having a genetic test
will differ between the UK and USA and might be an inhibiting factor in the USA [36,39].
Conversely, although testing is free through the National Health Service (NHS), patients
are not routinely given copies of their test results in the UK [16]. Consequently, we were
interested to find out whether access to digital copies of documents provided by their
health professional would be important to patients.
Informing relatives of a familial diagnosis can still be a challenging experience even
with appropriate information and guidance on how to disseminate information [40,41].
A personal conflict can be felt between someone’s rational decision to pass on informa-
tion to family members and their emotional unease at the potential disruption to family
relationships that might ensue [42,43]. We believe that it is unusual for patients to overtly
refuse to pass on information to their close relatives, but it is more common that disclosure
is incomplete [44,45]. Whatever the context, we would argue that what is important is to
sufficiently empower individuals to act in a way that is consistent with their beliefs and
ideals [46]. With the increasing use of technology in communication [47], it would appear
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logical to offer documents in both hard copy and digital format as this might be particularly
helpful to younger, less mobile or geographically distant relatives [48].
Defining what is deemed to be an effective intervention may not be confined to the
simple use of numbers of relatives contacted. Other measures have showed that sharing
information about a diagnosis was associated with the patients’ perception of how the
news would be received and whether the informant felt this was within their control [25]
consistent with the Theory of Planned Behaviour (TPB) [49]. Under the TPB, “perceived
personal control” is only one determinant of intention, which is also modified by people’s
“attitudes” and “subjective norms”; these taken together lead to people’s intentions to a
given behaviour. The controllability of certain behaviours is specific to individuals because
of what they perceive as the difficulty of performing the behaviour will depend on both
external factors (e.g., opportunity to exercise) and internal factors (e.g., knowledge of what
foods are beneficial). We suggest that this theory can also be applied to issues such as how
relatives might seek referral to genetics services and cancer surveillance.
An alternative theoretical framework which can be applied in this context is the
Health Belief Model (HBM) [50], where cancer risk reduction might be considered a
strong “perceived benefit” in response to the “perceived threat” to health posed by an
inherited vulnerability to cancer. Improved understanding of someone’s vulnerability
though better access to relevant literature or professional support could provide a “cue to
action”, although this could be dependent on the person’s self-efficacy, as found in relation
to dietary change in a study of patients with Lynch syndrome [51].
However, it can be difficult to quantify the effectiveness of risk communication in-
terventions because counting the number of people who choose not to access a service is
very challenging. Outcomes vary but have included counting the proportion of relatives
referred to genetic services [22] and patients’ own assessments of the number of relatives
they have informed [25]. Both these approaches are subject to error as they are reliant on
the patient understanding who needs to be informed, while relatives may wait an indefinite
time to seek testing or choose not to do so [12]. Consequently, we chose to investigate,
as a proof of concept, a method of disseminating digital documents to patients that was
designed to help them pass on information to their family members.
2. Materials and Methods
2.1. Design
We used a pragmatic mixed methods approach [52] which enabled us to gain a
more thorough understanding of the issues relating to the delivery of patient-specific
information in a healthcare setting [53,54]. With the intention of gathering information
with both breadth and depth, we used a convergent mixed method design [55]. This utilised
a questionnaire alongside qualitative interviews with a purposive sample of participants
drawn from survey respondents [55,56].
We first carried out a systematic literature review [57] in order to find the existing
evidence on methods of electronic communication used by health professionals to support
families communicating about a health issue. This literature review was carried out
across 10 electronic databases for the period of January 1990 to December 2017. Although
3587 articles were retrieved and 105 assessed in full text format, only one article by Bowen
and colleagues [58] was identified that met the criteria, thus demonstrating the dearth of
evidence in this area. However, these authors did emphasise the importance of alerting
family members to a shared health threat (risk of melanoma), which would enable relatives
to make informed choices about accessing screening or further advice [58,59].
2.2. Aims and Objectives
The aim of this research was to investigate whether a secure website could support
families at an increased risk of bowel cancer to share information with their relatives. This
research was performed as part of a doctoral study at the University of Plymouth, UK [60].
In order to achieve this, our four main objectives were:
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1. Explore the perspectives of patients, including their experiences of how they received
information about the familial diagnosis themselves;
2. Explore patients’ views about a secure website that provided a platform for patients
to share documents about their diagnosis with their relatives;
3. Investigate the feasibility and acceptability of sharing electronic documents regarding
a familial diagnosis securely online using the purpose built website;
4. Test the website’s function and acceptability with research participants [60] (p. 98).
2.3. Ethical Approval
Ethical approval was given by the Health Research Authority (HRA) South West Re-
search Ethics Committee (IRAS reference 15/SW/0250) and by the University of Plymouth
Faculty of Health Research Ethics Committee (reference 15/16-477).
2.4. Phase 1: Anonymous Cross-Sectional Survey
A cross sectional survey was used [60], administered both in paper format and on-
line (using SurveyMonkey https://www.surveymonkey.com/) (accessed on 27 February
2021) [61]. The questionnaire was designed to elicit the views of a broad cohort of individ-
uals living with a genetic vulnerability to bowel cancer. The text of the questionnaire is
presented in Appendix A. In this phase, we wanted to explore participants’ experiences
of being informed of the diagnosis and how that information was shared in the family.
Data security of this sensitive information was ensured through (SG’s) password protected
access to the responses submitted via SurveyMonkey, a platform considered sufficiently
secure for health related surveys [62–64] and approved by the Ethics Committee within the
study protocol [60].
2.4.1. Inclusion and Exclusion Criteria for Phases 1 and 2
Participants were over 17 years old and were either part of a family considered to
have an increased risk of bowel cancer due to their family history, where a genetic variant
had been found which conferred a high risk of bowel cancer, or because they had been
diagnosed with a cancer which was due to an inherited vulnerability, such as Lynch
syndrome [65]. The key aspect of eligibility was whether they or their relative had been
advised to have regular bowel screening by colonoscopy. Participants were not eligible if
they had only received their diagnosis (genetic or cancer) within the last three months or
if they were not competent in reading and speaking English. Language competence was
assessed by local recruiting clinicians, or through self-selection as Participant Information
Sheets (PIS) were provided in English only.
2.4.2. Recruitment to Phases 1 and 2
Recruitment to the survey was through (1) NHS clinics at six recruitment sites with
a paper copy questionnaire and (2) online via advertisements and links at four charity
websites (Lynch Syndrome UK, Bowel Cancer West, Beating Bowel Cancer and FAP Gene
Support Group). Information leaflets, the PIS and invitation letters were distributed in the
Endoscopy Clinic at an NHS Hospital Trust. In addition, invitation letters and appropriately
headed PIS were distributed to eligible patients at the five NHS clinical genetics services in
England and Wales.
2.4.3. Data Collection Phase 1 Survey
Data were collected through completion of the survey questionnaire, either online
or on paper. Participants completing and returning the anonymous survey questionnaire
were interpreted as giving assent to taking part, so explicit consent was not required for
this aspect of our study. Nominal categorical data were collected using fourteen multiple
choice questions. There were also six open questions with free text boxes inviting more
detailed responses or elaboration to some answers. In addition, one question had a Likert
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type scale [66] giving a range of options between “very unhelpful” and “very helpful” to
different formats for receiving information.
2.4.4. Data Analysis Phase 1 Survey
Qualitative data from free text responses were coded and analysed for recurrent
themes [67,68] by the first two authors, using NVivo qualitative data analysis software [69].
The quantitative data from the cross-sectional survey [70] were analysed using descriptive
statistics in Microsoft Excel (2016 version Microsoft, Redmond, WA, USA) and using SPSS
software (IBM SPSS statistics version 22 IBM Corporation, Armonk, NY, USA). Pearson’s
Chi Square or Fisher’s exact tests were used to give a measure of association between
categorical variables. The responses to the Likert type questions were analysed as ordinal
data using descriptive statistics and Chi-squared as a measure of association [66].
2.4.5. Recruitment Phase 2 Telephone Interviews
This phase of the study used a nested sampling design [71] where there was an
invitation at the end of the survey questionnaire for participants to take part in further
research. Tear off slips were laid out so that they could be separated from the questionnaire
and returned using the Freepost address. This meant that participants in Phase 2 could
have known about their diagnosis, or the diagnosis in the family, for some time and were
therefore drawn from the same population of patients as for Phase 1.
2.4.6. Sampling and Data Collection Telephone Interviews
Semi-structured telephone interviews were used to collect data from a purposive
sample of respondents to the survey, with maximum variation for age and educational
qualification and with equal numbers of men and women [56]. Participants had received
a PIS and consent forms prior to interview and their verbal consent was also taken prior
to interview. The digital recordings of the interviews were then transcribed to allow
coding and subsequent analysis by content and theme [67]. Participant confidentiality
was maintained through the use of pseudonyms and redacting any potentially identifiable
place names or data.
2.4.7. Data Analysis Phase 2
Data analysis was based on a qualitative thematic analysis approach using both deduc-
tive and inductive coding [67,72,73]. This was performed in order to develop information
most suited to the needs of the potential recipients and define concepts of interest or
concern. Coding was primarily deductive through content analysis and descriptive coding,
focusing on how the participant had been informed of their risk, how health issues were
communicated in the family and which topics they would like more information about.
Secondary analysis was inductive, focusing on the development of theories about what
helped or hindered communication in the family over health issues. Coding of transcripts
was carried out by two coders (S.G. and H.S.) independently and any differences in coding
were resolved through discussions until a consensus was reached.
2.5. Website Development
The Family Web website (https://www.familyweb.org.uk/) (accessed on 27 February
2021) was developed in response to the findings from Phases 1 and 2 of the study (Figure 1),
which mainly guided the content of the information resources. The structure of the website
was created by a web development company (https://www.modernwebsites.co.uk) (ac-
cessed on 27 February 2021). The brief had been to create a website that would function
as an alternative means of sharing health information securely with patients and their
at-risk relatives (Figure 2). It was therefore designed as a secure database where health
professionals, or patients, could upload documents in a range of digital file formats (e.g.,
pdfs, jpeg, word files) and set up secure online links to these documents which could then
be shared with relatives via email.
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2.6. Phase 3: Think-Aloud Interviews to Test Website Function
2.6.1. Data Collection
T e website was developed (Figure 4) and tested through an iterative series of twelve
Think-Aloud interviews [76] with eligible participants. These were semi-structured in-
terviews conducted through the online video conferencing platform GoToMeeting [77].
During each Think-Aloud interview, participants navigated through the website and voiced
their thoughts, at times prompted by the interviewer (SG). Each interview was recorded
to enable analysis and reflective notes were made during the interview, and immediately
afterwards, noting any issues or technical difficulties that had occurred. This type of
dynamic interview was used to capture each participant’s interaction with the website
alongside their verbalisation [78].
The criteria for eligibility were almost the same as quoted above (Section 2.4), but in
contrast to Phases 1 and 2 the people who were eligible for Phase 3 were more recently
diagnosed. We wished to recruit people who had only learnt about their genetic vulner-
ability to cancer within the last 24 months. This was because we wanted to interview
people who might still be in the process of sharing information with their relatives. Recruit-
ment was through the six existing NHS recruitment sites (only name, contact number and
email address were provided) and respondents to the online survey who had offered to be
interviewed via the reply slip. Following receipt of a PIS and consent form, potential inter-
viewees were contacted by telephone to explain the process of a Think-Aloud interview
and consent; signed forms were returned prior to interview.
Twelve Think-Aloud interviews were conducted, initially with four participants who
had no prior experience of the website. Subsequently, eight further interviews were
recorded after other participants had been given the opportunity to first explore the website
in their own time.
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2.6.2. Phase 3 Data Analysis
Video recordings were replayed several times, enabling SG to view them while mak-
ing notes about each participant’s comments and reactions to different elements of the
website. A matrix was created linking participant comments with their context and allowed
comparison between participants for each section of the website. Illustrative quotes were
identified through verbatim transcription of phrases. This was an iterative process which
identified themes and enabled the website to be refined in response to earlier participants’
comments and actions.
3. Results
3.1. Phase 1 Survey
Of 286 people who participated in the survey, 217 were women (77%). There was a
broad age distribution of participants with 68 (24%) under 40 years old and 145 (51%) were
50 years or older. Most responses were received from the online survey: 183/286 (64%).
Over half, 165/284 (58%), reported that they had never been diagnosed with cancer,
but 87 had experienced bowel cancer and 32 another type of cancer. The majority of
participants (249/286, 87%) reported that a genetic test was available in their family.
The largest proportion of participants (43%) had first been informed of the familial
diagnosis by a relative, most often their mother, while 28% were told by a genetics specialist
and 20% by another specialist. In addition, 88 (31%) were the index case in their families
with the main responsibility for passing on information to their other family members. The
survey question did not ask about specific numbers of relatives who had been informed
of the diagnosis but instead asked if “all”, “most”, “some” or “none” were aware of the
risk of cancer. Of those 88 index case participants, only three reported that none of their
relatives were aware, but only 29 (33%) indicated that “all” of their relatives knew about
their increased risk.
When comparing responses and distinguishing between those people who had been
educated to above or below degree level, there was an association between lower educa-
tional attainment and receiving no supporting information at the time of their diagnosis
(Fisher’s exact 10.24; p < 0.5). When asked about what, if any, information had been re-
ceived, 140 (49%) indicated “general information”. However, 40/124 (32%) of participants
had not received any written information when they had first learnt about the diagnosis
through their family member.
Despite this, most participants indicated that they had felt supported at the time
of their genetic diagnosis or when they first learnt about the increased vulnerability to
cancer in their family. Satisfaction with support was most often reported (104/148) if they
had received information from a health professional. Nonetheless, the majority, 193/256
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(75%), also wanted more information and support, ideally provided through a follow-up
appointment or via email. One comment in the free text responses summarised this well:
“Informal advice about how to broach this subject with relatives, some of whom I do not
see often and who are not local to my area. The ‘To whom it may concern’ letter is rather
too formal in my opinion” Survey Participant 49 [60].
When given options of which topics (“talking to children”, “healthy lifestyle”, “help-
ing relatives who live abroad”, “genetic testing” and “other”) participants wanted more
information about, most participants 140/286 (49%) indicated that they wanted more ad-
vice on how to have a “healthy lifestyle”, followed by “genetic testing” (44%) and “talking
to children” (34%).
3.2. Phase 2 Telephone Interviews
Data were collected through telephone interviews with a purposive sample of volun-
teers (six men and eight women) in order to understand some of the difficulties encountered
using the website and preferences for information of people of different ages and both sexes.
This number of interviews was sufficient to reach saturation of themes [79]. The volunteers
had ages ranging from 20 years to 68 years and 12 out of 14 of them had a diagnosis of
Lynch syndrome. Four major themes of “impact of the diagnosis”, “adaptation to the
diagnosis”, “appropriate communication” and “practical information” were identified and
Figure 5 below illustrates how these themes might interact.




Figure 5. Suggested interactions between major themes [60]. 
For the purpose of this paper, we will focus on the themes of “practical information” 
and “appropriate communication” as most relevant to the technological aspects of facili-
tating communication. 
Participants wanted more information to build on their understanding of the familial 
diagnosis and how best to mitigate the effects in practical ways. Advice on how a healthy 
diet and lifestyle could reduce their risk of cancer was commonly mentioned and included 
the use of aspirin [80,81]. Other topics which were frequently raised were: how to spot the 
early signs of cancer, how to talk to children about the diagnosis, the risks of different 
cancers associated with their genetic variant and how to access appropriate cancer screen-
ing. 
The participants who had already shared information about the diagnosis with their 
relatives described using a variety of different methods of communication. The type of 
communication depended on what was feasible, likely to suit the recipient and was con-
sidered appropriate for the task. One participant had taken on the role of family co-ordi-
nator and explained that he had used Facebook messenger when contacting his niece, 
while another printed out a letter to send to her elderly parent. In most cases, participants 
described how they had initially broken the news about the genetic diagnosis during a 
visit, so in person, or by telephone. This personal approach was considered ideal, but 
some recognised that physical or emotional distance might influence what they did. 
Many interview participants reported seeking information from the Internet and they 
considered the opportunity to store and share their own information via a secure website 
as being useful, as long as that was appropriate for the recipient. One person (Interview 
Subject 8) said: 
“I would use whatever was appropriate to the person I was talking to. So, you know, if I 
was trying to explain to my father then I would use a patient information leaflet. If I was 
trying to explain to my nieces, then I would say “Look at this website”” [60]. 
The content of written information was described as important by some, with the 
clinic summary letter often described as too personal, detailed and clinical to be shared. 
However, for several people the post clinic letter appeared to be the only written infor-
mation they had received. This aligned with other responses where participants explained 
that written information needed to be accurate but simple. This requirement impacted 
both on the patients themselves and on their relatives, as some participants described how 
they felt they had insufficient understanding to be confident explaining the condition to 
others. 
Figure 5. Suggested interactions between major themes [60].
For the purpose of this aper, we will focus on the themes of “practical informa-
tion” and “appropriate communication” as most relevant to the technological aspects of
facilitating communication.
Participants anted more information to build on their understanding of the famil-
ial diagnosis and how best to mitigate the effects in practical ways. Advice on how a
healthy diet and lifestyle could reduce their risk of cancer was commonly mentioned and
included the use of aspirin [80,81]. Other topics which were frequently raised were: how
to spot the early signs of cancer, how to talk to children about the diagnosis, the risks
of different cancers associated with their genetic variant and how to access appropriate
cancer screening.
The participants who had already shared information about the diagnosis with their
relatives described using a variety of different methods of communication. The type
of communication depended on what was feasible, likely to suit the recipient and was
considered appropriate for the task. One participant had taken on the role of family co-
ordinator and explained that he had used Facebook messenger when contacting his niece,
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while another printed out a letter to send to her elderly parent. In most cases, participants
described how they had initially broken the news about the genetic diagnosis during a
visit, so in person, or by telephone. This personal approach was considered ideal, but some
recognised that physical or emotional distance might influence what they did.
Many interview participants reported seeking information from the Internet and they
considered the opportunity to store and share their own information via a secure website
as being useful, as long as that was appropriate for the recipient. One person (Interview
Subject 8) said:
“I would use whatever was appropriate to the person I was talking to. So, you know, if I
was trying to explain to my father then I would use a patient information leaflet. If I was
trying to explain to my nieces, then I would say ‘Look at this website’” [60].
The content of written information was described as important by some, with the clinic
summary letter often described as too personal, detailed and clinical to be shared. However,
for several people the post clinic letter appeared to be the only written information they
had received. This aligned with other responses where participants explained that written
information needed to be accurate but simple. This requirement impacted both on the
patients themselves and on their relatives, as some participants described how they felt
they had insufficient understanding to be confident explaining the condition to others.
Talking more specifically about how they could use a secure website for sharing
information, one woman envisaged how her brother might find that accessing the in-
formation online might suit him while he was having trouble coming to terms with the
familial diagnosis:
“once he gets to that point where he feels “I can face it now” he can go and have a look and he
can find the information but he needs to do it in his own time” (Interview Subject 12) [60].
3.3. Results Phase 3 Think-Aloud Interviews
The Think-Aloud interviews captured comments (all names are pseudonyms) in
relation to initial impressions of the website in the first iteration with four users (Oliver,
Luke, Jane and Freya); experiences of the website after having access two days prior to
interview with four other users (Theo, Mike, Annie and Harry); and reflections particularly
around the document sharing function with access a week before the interview with a
further four users (Mark, Stella, Jenny and Keith). The participants in these interviews
were a purposive sample of interview volunteers with seven men (average age 52 years)
and five women (average age 45 years). The youngest participant was Freya (25 years) and
the oldest was Harry (69 years). The participants took part in a location of their choice,
visiting the website while being interviewed via an online video conferencing platform
(GoToMeeting) [77].
Initial impressions of the website were positive—the first four interview participants
all said how much they liked the look of the website (Figure 6); they were interested in
how it worked but they did not immediately understand the function of the website:
“I think the content looks really good and the way it is laid out is really good, it is
really clear . . .
. . . It’s not instantly clear what it is regarding . . . is this just about people with bowel
cancer awareness?” Luke (#2).
All these participants were drawn to the open access resources and two were enthu-
siastic about how these were laid out in sections under the title “Your Journey”. They
particularly appreciated the information provided about the importance of a healthy diet
in the “Living your Life” section:
“This is my favourite page of it all because these are the questions that I have had to go
away and find answers to myself” Oliver (#1).
One element that caused confusion to Freya (#4) was how users to the website were
invited to create free accounts but this was divided into “patient”, “family member” or
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“professional” account types. Freya explained that she was not sure she was a “patient” as
she had not had cancer, and she also related to being a “family member”.
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In response to comments by two of the participants, the graphic above (Figure 7) was
added to the website. The text on the homepage was also simplified with bullet points
introduced in order to provide a list at a glance and links with quick access to different
parts of the website.
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Anoth r area that received criticism was the section n bowel screening, which was
consi ered by some to have insufficient detail. One participant explained how screening
was the most important aspect of her diagnosis:
“How to get the right screening is quite important. Obviously diet, lifestyle, alcohol but
the screening is what is most important. People want to know what they have to do.”
Jenny (#11).
Along with information about other ways to reduce the risk of cancer, one participant
said ho he wanted others to be aware that colonoscopy was “nothing to be afraid of” Mike
(#6). Following these comments, a short video about colonoscopy was added to the site.
Other material that was changed following the interviews were: addition of information
about aspirin reducing risk of cancer; removal of a diagram of biological mechanisms
linking certain foods to cancer; provision of more information about the sign-up process to
make it clearer.
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Table 1 below provides a matrix of the specific changes made to different parts of
the website in response to reactions given in the Think-Aloud interviews, with interviews
numbered in chronological order denoted by #symbol and number.
Table 1. Changes made to the website linked to suggestions given in TA interviews [60].
Interview Area of Site Suggestions for Improvement Changed
#4, #6, #9, #10 Home page
Need to say what people can do, what they
can find on the site, at a glance list showing
relevance to users.
Bullet points added with short cuts to






Banner picture too big, you have to scroll
down to see text.
More explanation needed about what
website function is.
Some pictures removed or reduced in size.
Graphic created to show function of the
website.
#4 Accountinformation
Banner picture unnecessary, just obscures
information Banner picture removed
#7, #12
#1, #6 Patient sign up
Problems with creating username
Need more directions for sign-up
Added statement that username must be in
lower case letters
Text added to explain account activation
needed before use.





No partner as option in drop down list of
relatives
Blue folder icon meaningless
‘Partner’ added as an option to drop-down
list






Disliked biological mechanisms graphic.
Screening very important so wanted more
information about it.
Information about aspirin & CAPP3
Some pictures distract from the text.
Biological mechanisms graphic moved to
another page.
Added more information about colonoscopy
Information about aspirin added
Picture reduced in size
#6 Useful websites More links to different sites wanted
More websites added, including link to
CAPP3 study and NICE guidelines re
tumour testing.
How the inherited condition was presented was seen as critical by some participants,
who explained that in order to feel motivated to share the news of the diagnosis they
needed to feel that there was some benefit for their relatives. Freya (#4) said that the
positive messages needed more prominence and drew attention to the potential protective
effect of diet and exercise, saying:
“I would put that right at the top. Something like.. healthy diet, exercise, everything
that is good for everyone but you are at higher risk and it makes even more of a difference
for you.”
Freya (#4) also specifically explained that she needed to have hope and know the
benefits of her genetic status in order to have the motivation to act on that information,
rather than just experience it as bad news. This in turn would enable her to share those
explanations of benefit to other people in her family.
Two users in the third phase of Think-Aloud interviews were particularly enthusiastic
about the opportunity the website gave them to give their family members access to
documents at a time of their choosing. One user described how her teenage grandchildren
might feel uncomfortable talking to her about their bowels: she also thought that they might
want to read the information when they could be on their own. Some of the key elements
that the users described as important are illustrated above (Figure 8). Overall, the Think-
Aloud interviews demonstrated that the website provided functions that were welcomed
by users, its appearance was pleasing and there were only minor adjustments needed.
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4. Discussion
This study provides new evidence that patients would use a web-based file sharing
facility, such as the FamilyWeb website. It demonstrates the proof of concept that a website
that is used by patients to share digital documents with their family can be feasible. We
have demonstrated the content and functionality of such a website that we were able to
design and which we were able to adapt in response to patient users. We b lieve that this
r search has made a significant c ntribution to u d rstanding what factors influence the
diss mination of information in families in this cont xt. Participants sought information
which was tailored to their needs, which was offered through uplo ding patient-specific
d cuments. This finding is co sistent wit other studies [82] which have found that
patients expec ed a range of information sources and at a level of complexity that suited
their particular n eds. Whether use of this type of tech ology could translate into increased
cascade testing and screening would depend on whe her it was utilised by health care
providers [83], patie ts their relatives.
4.1. Practical Advice and the Theory of Planned Behaviour
We suggest that users might experience greater “perceived behavioural control” over
their likelihood of developing cancer when they have access to information that enables
them to act towards reducing their risk, such as dietary advice or aspirin use. In this
context, the Theory of Planned Behaviour [34,83,84] can be used to describe determinants
of behaviour and could predict why receiving practical advice was reported to be important
by many of the participants. Improved understanding and feelings of hope attributed to
greater “perceived behavioural control” could motivate patients to share documents with
their relatives. In addition, our results indicated that some participants anticipated that
sharing information in this way would be approved of by their relatives, such as the website
user who believed her teenage grandchildren would prefer to view documents online.
Conversely, some of the participants in this study reported feeling uncertain about
what they should tell their family members or they lacked confidence in their own under-
standing of the relevant issues, so “lacked perceived behavioural control”. The information
they had received was often not considered appropriate for the task so they welcomed the
opportunity to have further appointments with their genetics health professional or receive
more information (via an email or a website). It was also clear from all phases of the study
that participants valued practical advice and were seeking ways to reduce the uncertainty
they felt about the impact of their diagnosis on their lives. What they wanted was practical
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information written in a simple and accessible format that had content which was directly
relevant to them.
4.2. Information That Is Trustworthy and Accurate
Evidence suggests that patients want tailored information from trustworthy sources [84,85].
Participants to this study wanted more support from health professionals to access ap-
propriate cancer surveillance and they looked for a positive message about the genetic
diagnosis to share with their relatives. We suggest that when information comes from a
trusted source, it provides users with greater confidence. If someone has an inaccurate
or insufficient understanding of the implications of the familial diagnosis for their own
health [86], it is less likely that they will access the appropriate screening or share that
information with other relatives. Providing open access resources via a website along-
side information which demonstrates its authenticity (e.g., NHS badging) provides the
opportunity to create a trustworthy source of guidance which can be updated as new
evidence emerges. This means that a website of this type with ongoing curation could
be used as a powerful tool in education and dissemination of advice to people living
with an increased risk of cancer. All of the open access resources could be considered as
“educational materials” as they were written with the intention of informing readers on
aspects relating to the familial diagnosis, such as how to “share the news” of the diagnosis,
what might reduce their risk of cancer through adopting a healthy lifestyle and informa-
tion about bowel cancer and colonoscopy that might be useful to relatives in a “before
diagnosis” section. Previous research in families with Lynch syndrome in the USA had
shown associations between receiving educational material and seeking genetic advice.
The retrospective questionnaire-based study would have been liable to errors of recall but
showed that significantly more relatives who received educational materials went on to
seek advice from a health professional compared to those that received no materials [87].
4.3. Positive Framing of Information
Many participants appeared to feel motivated to help their relatives access appropriate
healthcare and several groups have already described how patients wish to protect their
family members [29,43,88]. Users to the website said how they liked the positive stance of
the resources. Information that gave hope and indicated a benefit to knowing genetic status
was perceived as a potentially motivating factor by some participants. This finding concurs
with McAllister’s theory of engagement, within which she suggested that someone’s
negative response to knowing their high risk of cancer was ameliorated if they understood
the benefits of bowel screening [89]. Our finding could also link to theories proposed by
Lafreniere and colleagues [90], who found evidence in families with HBOC that the initial
reactions of family members influenced how someone might attempt to communicate with
other relatives; if they were listened to and received positively this reinforced the action
and encouraged them to further communication within the family.
However positive the message, the process of attempting to inform other family mem-
bers about the familial diagnosis can be greeted with anger, denial or disagreement [43,91].
We acknowledge that not all relatives may wish to know about the genetic vulnerability
to cancer in their family [15]. Choosing not to seek genetic counselling or have genetic
testing can be a legitimate choice and a valid protective mechanism for some relatives. The
Health Belief Model [50,92] describes how an individual’s behaviour can be conceptualised
in terms of the perceived threat that the condition presents to them and whether they
experience any conflict between their self-efficacy and the perceived barriers or benefits
of behaviour change. Since someone’s assessment of the level of threat is likely to be
dependent on their understanding and their self-efficacy, we would argue that it remains
imperative that relatives have access to clear, factual information which is written to
explain the benefits of knowing their genetic status as well as the medical implications.
The methods for providing that information need to be in whatever format is most ap-
propriate for that person, so ideally available in several formats (leaflet, letter, digital
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document, video, social media). One motive for this research was the increasing rates of
bowel cancer diagnosed in younger people [93], and we would argue that it is therefore
particularly important to use online methods of disseminating information in a manner
likely to promote empowerment.
4.4. Study Limitations
Creation of The FamilyWeb website was an attempt to address some of the problems
associated with family communication, using a secure site. This created a facility for health
professionals to upload reports or letters to provide an encrypted link for patients to access
their own reports and letters. In turn, patients could choose to share specific documents
with as many relatives as they wished. Clinicians at the recruitment sites did not actively
engage with this process of uploading documents because they had delegated recruitment
to their research teams, so a next step in this research would be to test this function within
clinical practice with health care professionals providing patients with copies of reports via
the website. Developing a robust protocol to investigate the use of the website with health
professionals might be informed by the Technology Acceptance Model, where key variables
of “perceived usefulness” and “perceived ease of use” should be assessed [94]. We also
recognise that the transmission of information as a proxy indicator of communication
is too simplistic; sharing information may occur as a single event (transmitter–receiver)
but this does not take into account the perspectives of the receiver [95]. Another element
of technology adoption is likely to be trust in the security of the site. While the security
of our website was adequate for this study, we recognise that maintaining security is
an ongoing process and that trust would develop over time. Further work would be
needed in collaboration with NHS IT departments to ensure security was acceptable and
develop trust.
Another limitation was that participants were asked for their postcode as a proxy
for geographical location within the UK but ethnicity was not captured as part of the
demographic data. The greatest proportion of survey participants were recruited through
a Genetics Service which serves an ethnically diverse population, but we have no evidence
of how accessible or appropriate the website was to different ethnic groups, so this needs
to be addressed in future research.
4.5. Research Recommendations
We did not seek to test the efficacy of the website in disseminating documents; how-
ever, this could be achieved through further website development. The research reported
here demonstrated a proof of principle that a website of this kind could function as a means
of providing patients with access to their confidential documents (clinic letters, test results,
screening reports) if they were uploaded to the site by their clinician.
The current build of the website would allow the collection of data on the number of
documents shared with relatives and how many of those relatives accessed each document,
in addition to the number of views of each page or resource. The website also logs the
times that users and relatives access the website, distinguishing between different relatives
by assigning a unique number to each person (since their identity is unknown). This
means that it would be straightforward to calculate the proportion of relatives who actively
engage with the website and view the documents for which they have been sent links.
However, it would not be possible to determine the relationship and level of risk of each
family member contacted without requesting such data through a user survey.
Currently the website does not recognise if a new user who creates an account was
previously someone who was sent an encrypted link by their family member, but this
function could be built in to enable the website to track the cascade effect of using the
website to disseminate information within a family. Therefore, this website, or a Personal
Health Record system which incorporated the same functions, could be used as a tool to
collect such data within a larger study.
Cancers 2021, 13, 2404 16 of 22
In Finland, Denmark, Australia and the Netherlands, initiatives have already been
taken to investigate the feasibility and acceptability of contacting at-risk relatives directly
rather than relying on a family-mediated approach to disseminate information about
genetic diagnoses [8,12,96,97]. Although direct contact was not envisioned as a use for the
website, health professionals could send encrypted links directly to a patient’s relatives via
email with the prior consent of that patient. This approach has already been suggested in
the context of familial hypercholesterolaemia as a way of reducing the burden on patients
by using software to inform relatives directly [98].
We focused on facilitating communication in families at increased risk of bowel cancer,
but it would be a logical step to investigate whether the same approach could be used
across other genetic conditions. We would echo the sentiments of Schwiter et al. in their
recent mini-review of communication and cascade testing uptake [19] that web-based
content could be made available to families in a format that could be engaging, but also
affordable and sustainable. Their finding supports that of other authors [99–101] that
tailored information is more likely to be seen as relevant and is particularly beneficial to
patients. Consequently, we would intend to collect data on how tailored information can
be optimised in a future pilot study of the website within a clinical context.
The content of the Family Web website could be changed or extended to be relevant
to many different patient groups, but we do also acknowledge that the functionality of this
type of secure database is already built in to some existing Personal Health Record systems.
What is lacking is robust research evidence to demonstrate their efficacy at disseminating
information in families because this would not have been regarded as a primary function
at their inception. However, in the wake of the COVID-19 pandemic, there may be an
increase in research which utilises technology to assist in communication due to the rapid
adoption of novel methods of service delivery during the crisis [102].
5. Conclusions
This research has provided a proof of principle that providing patient-specific docu-
ments securely online is both feasible and acceptable to patients. In the past, the growing
use of digital communication (email, video call, social media) has not been reflected in
health communication due to concerns about security and confidentiality. In publicly
funded health systems, such as the NHS, patients are reliant on the health professionals
who order their tests and typically they do not receive copies of their reports; consequently,
individuals may not possess the material that could empower them [103]. We are more
optimistic that there has been an accelerated adoption of technology in health since the
COVID-19 pandemic [104], which could translate into increased use of innovations such as
our website to facilitate communication in families.
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Appendix A
1. Who first told you that there was a risk of bowel cancer in your family?
Please tick one:
 Your doctor (General Practitioner “GP”)
 Specialist doctor (e.g., surgeon, gastroenterologist, oncologist, etc.)
 Genetics specialist (e.g., medical doctor or genetic counsellor)
 Another healthcare professional
 Your relative, can you tell us who? (e.g., mother, brother, cousin?)
Other person, please tell us who? (e.g., friend or charity advisor?)
 Can’t remember
Please answer the next questions (2, 3 & 4) only if you were told about the increased risk by a healthcare professional
2. Did you feel well supported at that time? Yes/No/Not sure
3. Please give suggestions below if you think that this could have been done better?
4. Are you the first person in your family to be told that there is an increased risk of cancer in the family?
Yes/No/Don’t know
5. Please can you tell us what written information you received when you were told about your risk of cancer? Tick all that apply
 None received
 General information about the condition
 Specific information about your family
 A copy of your family tree indicating who had cancer
 A copy of your family tree showing who could have bowel screening
 A ‘Dear Relative’ or ‘To Whom it May Concern’ letter to give to your relatives
 Other—Please give details
6. Did you get the information you wanted?
 None of what I wanted
 Some of what I wanted
 Most of what I wanted
 All of what I wanted
6a. If you didn’t get all the information you wanted at that time, what other information might have been helpful? Please tell us . . .
7. If you have found additional information about the shared risk of cancer in your family, who provided that information? Tick all
that apply
 Your doctor, surgeon or other health professional
 Other relatives
 Friends




8. If you found out more information via the Internet, what websites or social media were particularly helpful?
Please give details below:
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9. Would you like to receive information in other ways? Yes/No/Don’t know
If yes, would this be
 Via a website
 By Email
 Social media
 In a follow-up appointment
 Other—Please state
We would like to know if other forms of information for patients could make it easier to share information in the family. Below, we
ask you to think about other ways that your doctor or genetic counsellor could give you information. Then please can you rate how
helpful these might be to you and your relatives?
10. Please indicate how helpful you think this would be for the different ways of getting information by making a cross on each of
the scales below:
a. A paper leaflet which has general information about an increased risk of bowel cancer, the implications for relatives and the
screening available?
b. A secure email which has more specific information about your increased risk, the implications for your relatives and the
screening advised?
c. A password protected website which has more specific information about your increased risk, the implications for your relatives
and the screening advised ?
d. A follow-up appointment in the hospital clinic where you are given specific information about your increased risk, the
implications for your relatives and the screening advised?
e. A follow-up telephone call where you are given specific information about your increased risk, the implications for your relatives
and the screening advised?
11. What issues would you like more information about? Please tick all that apply
 Talking to children
 Healthy lifestyle
 How can I help my relatives who live abroad
 How to find out more about genetic testing
 Other issues
Please give us more details about any of the issues that concern you in the box below:
12. How many of your relatives are aware of the increased risk of cancer in the family?
So, as far as you know
 All
 Most (please tick the one which applies)
 Some
 None
 I don’t know
13. If you have experienced any difficulties sharing information with your relatives about the increased risk can you tell us what
those difficulties were?
Please give details below, or pass on to the next question if there were no difficulties
14. Can you suggest ways in which your health professional could help you or your family more? Please give suggestions below.
Final page of the questionnaire was of demographic questions
References
1. Foulkes, W.D. Inherited Susceptibility to Common Cancers. New Engl. J. Med. 2008, 359, 2143–2153. [CrossRef] [PubMed]
2. Torre, L.A.; Siegel, R.L.; Ward, E.M.; Jemal, A. Global Cancer Incidence and Mortality Rates and Trends–An Update. Cancer
Epidemiol. Biomark. Prev. 2015, 25, 16–27. [CrossRef]
3. Møller, P.; Seppälä, T.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Evans, D.G.; Lindblom, A.; Macrae, F.; Blanco, I.; Sijmons, R.
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: First report
from the prospective Lynch syndrome database. Gut 2017, 66, 464–472. [CrossRef] [PubMed]
4. Grosse, S.D.; Rogowski, W.H.; Ross, L.F.; Cornel, M.C.; Dondorp, W.J.; Khoury, M.J. Population Screening for Genetic Disorders
in the 21st Century: Evidence, Economics, and Ethics. Public Heal. Genom. 2010, 13, 106–115. [CrossRef]
5. Seppälä, T.T.; Pylvänäinen, K.; Mecklin, J.-P. Uptake of genetic testing by the children of Lynch syndrome variant carriers across
three generations. Eur. J. Hum. Genet. 2017, 25, 1237–1245. [CrossRef] [PubMed]
6. Newton, K.; Gréen, K.; Lalloo, F.; Evans, G.; Evans, D.G.; Hill, J. Colonoscopy screening compliance and outcomes in patients
with Lynch syndrome. Color. Dis. 2014, 17, 38–46. [CrossRef] [PubMed]
7. Vasen, H.F.A.; Velthuizen, M.E.; Kleibeuker, J.H.; Menko, F.H.; Nagengast, F.M.; Cats, A.; Jong, A.E.V.D.M.-D.; Breuning, M.H.;
Roukema, A.J.; Van Leeuwen-Cornelisse, I.; et al. Hereditary cancer registries improve the care of patients with a genetic
predisposition to cancer: Contributions from the Dutch Lynch syndrome registry. Fam. Cancer 2016, 15, 429–435. [CrossRef]
Cancers 2021, 13, 2404 19 of 22
8. Petersen, H.V.; Frederiksen, B.L.; Lautrup, C.K.; Lindberg, L.J.; Ladelund, S.; Nilbert, M. Unsolicited information letters to increase
awareness of Lynch syndrome and familial colorectal cancer: Reactions and attitudes. Fam. Cancer 2018, 18, 43–51. [CrossRef]
9. Adelson, M.; Pannick, S.; East, J.E.; Risby, P.; Dawson, P.; Monahan, K.J. UK colorectal cancer patients are inadequately assessed
for Lynch syndrome. Front. Gastroenterol. 2013, 5, 31–35. [CrossRef]
10. Monahan, K.J.; Alsina, D.; Bach, S.; Buchanan, J.; Burn, J.; Clark, S.; Dawson, P.; De Souza, B.; Din, F.V.N.; Dolwani, S.; et al.
Urgent improvements needed to diagnose and manage Lynch syndrome. BMJ 2017, 356, j1388. [CrossRef]
11. Sharaf, R.N.; Myer, P.; Stave, C.D.; Diamond, L.C.; Ladabaum, U. Uptake of Genetic Testing by Relatives of Lynch Syndrome
Probands: A Systematic Review. Clin. Gastroenterol. Hepatol. 2013, 11, 1093–1100. [CrossRef] [PubMed]
12. Menko, F.H.; Ter Stege, J.A.; Van Der Kolk, L.E.; Jeanson, K.N.; Schats, W.; Moha, D.A.; Bleiker, E.M.A. The uptake of presymp-
tomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: A systematic review of the literature and
implications for clinical practice. Fam. Cancer 2018, 18, 127–135. [CrossRef]
13. Snowsill, T.M.; Ryan, N.A.J.; Crosbie, E.J.; Frayling, I.M.; Evans, D.G.; Hyde, C.J. Cost-effectiveness analysis of reflex testing for
Lynch syndrome in women with endometrial cancer in the UK setting. PLoS ONE 2019, 14, e0221419. [CrossRef]
14. Kang, Y.; Killen, J.; Caruana, M.; Simms, K.; Taylor, N.; Frayling, I.M.; Snowsill, T.; Huxley, N.; Coupe, V.M.; Hughes, S.; et al. The
predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Med.
J. Aust. 2019, 212, 72–81. [CrossRef]
15. Cowley, L. What can we Learn from Patients’ Ethical Thinking about the right ‘not to know’in Genomics? Lessons from Cancer
Genetic Testing for Genetic Counselling. Bioethics 2016, 30, 628–635. [CrossRef] [PubMed]
16. Dheensa, S.; Lucassen, A.; Fenwick, A. Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: A
Qualitative Study with Patients and Healthcare Professionals. J. Genet. Couns. 2018, 27, 689–701. [CrossRef] [PubMed]
17. Snyder, C.; Hampel, H. Hereditary Colorectal Cancer Syndromes. Semin. Oncol. Nurs. 2019, 35, 58–78. [CrossRef]
18. Campbell-Salome, G.; Buchanan, A.H.; Hallquist, M.L.; Rahm, A.K.; Rocha, H.; Sturm, A.C. Uncertainty management for
individuals with Lynch Syndrome: Identifying and responding to healthcare barriers. Patient Educ. Couns. 2021, 104, 403–412.
[CrossRef]
19. Schwiter, R.; Rahm, A.K.; Williams, J.L.; Sturm, A.C. How Can We Reach At-Risk Relatives? Efforts to Enhance Communication
and Cascade Testing Uptake: A Mini-Review. Curr. Genet. Med. Rep. 2018, 6, 21–27. [CrossRef]
20. De Geus, E.; Aalfs, C.M.; Verdam, M.G.; De Haes, H.C.; Smets, E.M. Informing relatives about their hereditary or familial cancer
risk: Study protocol for a randomized controlled trial. Trials 2014, 15, 86. [CrossRef]
21. De Geus, E.; Eijzenga, W.; Menko, F.H.; Sijmons, R.H.; De Haes, H.C.J.M.; Aalfs, C.M.; Smets, E.M.A. Design and Feasibility of an
Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives. J. Genet. Couns. 2016, 25, 1179–1187.
[CrossRef] [PubMed]
22. Hodgson, J.; Metcalfe, S.; Gaff, C.; Donath, S.; Delatycki, M.B.; Winship, I.; Skene, L.; Aitken, M.; Halliday, J. Outcomes of a
randomised controlled trial of a complex genetic counselling intervention to improve family communication. Eur. J. Hum. Genet.
2016, 24, 356–360. [CrossRef] [PubMed]
23. Hodgson, J.M.; Metcalfe, S.A.; Aitken, M.; Donath, S.M.; Gaff, C.L.; Winship, I.M.; Delatycki, M.B.; Skene, L.L.; McClaren, B.J.;
Paul, J.L.; et al. Improving family communication after a new genetic diagnosis: A randomised controlled trial of a genetic
counselling intervention. BMC Med. Genet. 2014, 15, 33. [CrossRef]
24. Eisler, I.; Ellison, M.; Flinter, F.; Grey, J.; Hutchison, S.; Jackson, C.; Longworth, L.; MacLeod, R.; McAllister, M.; Metcalfe, A.; et al.
Developing an intervention to facilitate family communication about inherited genetic conditions, and training genetic counsellors
in its delivery. Eur. J. Hum. Genet. 2016, 24, 794–802. [CrossRef]
25. Montgomery, S.V.; Barsevick, A.M.; Egleston, B.L.; Bingler, R.; Ruth, K.; Miller, S.M.; Malick, J.; Cescon, T.P.; Daly, M.B. Preparing
individuals to communicate genetic test results to their relatives: Report of a randomized control trial. Fam. Cancer 2013, 12,
537–546. [CrossRef] [PubMed]
26. Bodurtha, J.N.; McClish, D.; Gyure, M.; Corona, R.; Krist, A.H.; Rodríguez, V.M.; Maibauer, A.M.; Borzelleca, J.; Bowen, D.J.;
Quillin, J.M. The KinFact Intervention—A Randomized Controlled Trial to Increase Family Communication About Cancer History.
J. Women’s Heal. 2014, 23, 806–816. [CrossRef]
27. Kardashian, A.; Fehniger, J.; Creasman, J.; Cheung, E.; Beattie, M.S. A Pilot study of the Sharing Risk Information Tool (ShaRIT)
for Families with Hereditary Breast and Ovarian Cancer Syndrome. Hered. Cancer Clin. Pr. 2012, 10, 4. [CrossRef]
28. Smith, R.A. Picking a Frame for Communicating About Genetics: Stigmas or Challenges. J. Genet. Couns. 2007, 16, 289–298.
[CrossRef]
29. Mendes, Á.; Chiquelho, R.; Santos, T.A.; Sousa, L. Supporting families in genetic counselling services: A psychoeducational
multifamily discussion group for at-risk colorectal cancer families. J. Fam. Ther. 2015, 37, 343–360. [CrossRef]
30. Mendes, Álvaro; Chiquelho, R.; Santos, T.A.; Sousa, L. Family matters: Examining a multi-family group intervention for women
with BRCA mutations in the scope of genetic counselling. J. Community Genet. 2010, 1, 161–168. [CrossRef]
31. Katapodi, M.C.; Jung, M.; Schafenacker, A.M.; Milliron, K.J.; E Mendelsohn-Victor, K.; Merajver, S.D.; Northouse, L.L.;
Underhill, M.; Son, Y.A. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives:
Acceptability, Feasibility, and Usability Study. JMIR Cancer 2018, 4, e7. [CrossRef] [PubMed]
32. Jones, R.; Pearson, J.; McGregor, S.; Cawsey, A.J.; Barrett, A.; Craig, N.; Atkinson, J.M.; Gilmour, W.H.; McEwen, J. Randomised
trial of personalised computer based information for cancer patients. BMJ 1999, 319, 1241–1247. [CrossRef] [PubMed]
Cancers 2021, 13, 2404 20 of 22
33. Seven, M.; Shah, L.L.; Daack-Hirsch, S.; Yazici, H. Experiences of BRCA1/2 Gene Mutation–Positive Women with Cancer in
Communicating Genetic Risk to Their Relatives. Cancer Nurs. 2021, 44, E142–E150. [CrossRef]
34. Myers, M.; Conrad, P.; Blanco, A.; Terdiman, J. Kintalk: A novel web based communication tool for families with Lynch syndrome
to share genetic information. Fam. Cancer 2013, 12, 800.
35. Myers, M.; Conrad, P.; Terdiman, J. Kintalk.org: Helping Families Communicate Their Genetic Information. Curr. Oncol. 2014,
21, e363.
36. Hampel, H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam. Cancer 2016, 15, 423–427. [CrossRef]
37. Lynch, H.T.; Snyder, C.; Stacey, M.; Olson, B.; Peterson, S.; Buxbaum, S.; Shaw, T.; Lynch, P. Communication and technology in
genetic counseling for familial cancer. Clin. Genet. 2014, 85, 213–222. [CrossRef] [PubMed]
38. Kruk, M.E.; Kelley, E.; Syed, S.B.; Tarp, F.; Addison, T.; Akachi, Y. Measuring quality of health-care services: What is known and
where are the gaps? Bull. World Heal. Organ. 2017, 95, 389–389A. [CrossRef]
39. Jooma, S.; Hahn, M.J.; Hindorff, L.A.; Bonham, V.L. Defining and achieving health equity in genomic medicine. Ethn. Dis. 2019,
29 (Suppl. 1), 173. [CrossRef]
40. Metcalfe, A. Sharing Genetic Risk Information: Implications for Family Nurses Across the Life Span. J. Fam. Nurs. 2018, 24,
86–105. [CrossRef] [PubMed]
41. Keenan, K.F.; Simpson, S.A.; Wilson, B.J.; van Teijlingen, E.R.; McKee, L.; Haites, N.; Matthews, E. ’It’s their blood not mine’:
Who’s responsible for (not) telling relatives about genetic risk? Health Risk Soc. 2005, 7, 209–226. [CrossRef]
42. Clarke, A.J.; Wallgren-Pettersson, C. Ethics in genetic counselling. J. Community Genet. 2019, 10, 3–33. [CrossRef]
43. Seymour, K.C.; Addington-Hall, J.; Lucassen, A.M.; Foster, C.L. What Facilitates or Impedes Family Communication Following
Genetic Testing for Cancer Risk? A Systematic Review and Meta-Synthesis of Primary Qualitative Research. J. Genet. Couns. 2010,
19, 330–342. [CrossRef]
44. Gaff, C.L.; Clarke, A.J.; Atkinson, P.; Sivell, S.; Elwyn, G.; Iredale, R.; Thornton, H.; Dundon, J.; Shaw, C.; Edwards, A. Process and
outcome in communication of genetic information within families: A systematic review. Eur. J. Hum. Genet. 2007, 15, 999–1011.
[CrossRef] [PubMed]
45. Goldman, A.; Metcalfe, A.; MacLeod, R. The Process of Disclosure: Mothers’ Experiences of Communicating X-Linked Carrier
Risk Information to At-Risk Daughters. J. Genet. Couns. 2018, 27, 1265–1274. [CrossRef]
46. McAllister, M.; Dearing, A. Patient reported outcomes and patient empowerment in clinical genetics services. Clin. Genet. 2014,
88, 114–121. [CrossRef] [PubMed]
47. Poushter, J. Smartphone Ownership and Internet Usage Continues to Climb in Emerging Economies but Advanced Economies
Still Have Higher Rates of Technology Use. 2016. Available online: http://www.pewglobal.org/2016/02/22/smartphone-
ownership-and-internet-usage-continues-to-climb-in-emerging-economies/ (accessed on 14 September 2016).
48. Duggan, M. Mobile Messaging and Social Media 2015. Available online: http://www.pewinternet.org/2015/08/19/mobile-
messaging-and-social-media-2015/ (accessed on 5 September 2016).
49. Ajzen, I. Perceived Behavioral Control, Self-Efficacy, Locus of Control, and the Theory of Planned Behavior1. J. Appl. Soc. Psychol.
2002, 32, 665–683. [CrossRef]
50. Rosenstock, I.M.; Strecher, V.J.; Becker, M.H. Social Learning Theory and the Health Belief Model. Heal. Educ. Q. 1988, 15, 175–183.
[CrossRef]
51. Visser, A.; Vrieling, A.; Murugesu, L.; Hoogerbrugge, N.; Kampman, E.; Hoedjes, M. Determinants of adherence to recommenda-
tions for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration. PLoS ONE 2017, 12, e0178205.
[CrossRef]
52. Borglin, G. The Value of Mixed Methods for Researching Complex Interventions. In Complex Interventions in Health; Routledge:
New York, NY, USA, 2015.
53. Ivankova, N.V.; Creswell, J.W.; Stick, S.L. Using Mixed-Methods Sequential Explanatory Design: From Theory to Practice. Field
Methods 2006, 18, 3–20. [CrossRef]
54. Tashakkori, A.; Teddlie, C. SAGE Handbook of Mixed Methods in Social & Behavioral Research; SAGE Publications, Ltd.: New York,
NY, USA, 2010.
55. Mayoh, J.; Bond, C.S.; Todres, L. An Innovative Mixed Methods Approach to Studying the Online Health Information Seeking
Experiences of Adults With Chronic Health Conditions. J. Mix. Methods Res. 2011, 6, 21–33. [CrossRef]
56. Bryman, A. Integrating quantitative and qualitative research: How is it done? Qual. Res. 2006, 6, 97–113. [CrossRef]
57. CRD. Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care; Centre for Reviews and Dissemination: York, UK, 2009.
58. Bowen, D.J.; Albrecht, T.; Hay, J.; Eggly, S.; Harris-Wei, J.; Meischke, H.; Burke, W. Communication Among Melanoma Family
Members. J. Heal. Commun. 2017, 22, 198–204. [CrossRef]
59. Bowen, D.J.; Hay, J.L.; Harris-Wai, J.N.; Meischke, H.; Burke, W. All in the family? Communication of cancer survivors with their
families. Fam. Cancer 2017, 16, 597–603. [CrossRef] [PubMed]
60. Goodman, S. Supporting Information Sharing in Families at Risk of Bowel Cancer through a Secure Website. Ph.D. Thesis,
University of Plymouth, Plymouth, UK, 2018.
61. Stern, M.J.; Bilgen, I.; Dillman, D.A. The State of Survey Methodology Challenges, Dilemmas, and New Frontiers in the Era of the
Tailored Design. Field Methods 2014, 26, 284–301. [CrossRef]
Cancers 2021, 13, 2404 21 of 22
62. Creswell, J.W.; Hirose, M. Mixed methods and survey research in family medicine and community health. Fam. Med. Community
Heal. 2019, 7, e000086. [CrossRef]
63. Rea, A.; Marshall, K.; Farrell, D. Capability of web-based survey software: An empirical review. Am. J. Bus. 2021, ahead-of-p.
[CrossRef]
64. Cormier, J.; Iorio-Morin, C.; Mathieu, D.; Ducharme, S. Psychiatric Neurosurgery: A Survey on the Perceptions of Psychiatrists
and Residents. Can. J. Neurol. Sci. J. Can. des Sci. Neurol. 2019, 46, 303–310. [CrossRef]
65. Cohen, S.A.; Leininger, A. The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.
Appl. Clin. Genet. 2014, 7, 147–158. [CrossRef]
66. Boone, H.N.; Boone, D.A. Analyzing likert data. J. Ext. 2012, 50, 1–5.
67. Joffe, H.; Yardley, L. 4. Content and Thematic Analysis. In Research Methods for Clinical and Health Psychology; Sage: Thousand
Oaks, CA, USA, 2004; pp. 56–68.
68. Leech, N.L.; Onwuegbuzie, A.J. Beyond constant comparison qualitative data analysis: Using NVivo. Sch. Psychol. Q. 2011, 26,
70–84. [CrossRef]
69. QSR International Pty Ltd. NVivo Qualitative Data analysis Software, 10th ed.; QSR International Pty Ltd: Victoria, Australia, 2012.
70. Colton, D.; Covert, R.W. Designing and Constructing Instruments for Social Research and Evaluation; John Wiley & Sons: Hoboken, NJ,
USA, 2007.
71. Onwuegbuzie, A.; Collins, K. A Typology of Mixed Methods Sampling Designs in Social Science Research. Qual. Rep. 2015, 12,
281–316. [CrossRef]
72. Boyatzis, R.E. Transforming Qualitative Information: Thematic Analysis and Code Development; Sage Publications: London, UK, 1998.
73. Strauss, A.; Corbin, J. Basics of Qualitative Research: Procedures and Techniques for Developing Grounded Theory; Sage: Thousand Oaks,
CA, USA, 1998.
74. National Data Guardian. Review of Data Security, Consent and Opt-Outs; UK Government: London, UK, 2016.
75. Caldicott, F. Caldicott Review: Information Governance in the Health and Care System; National Data Guardian, Ed.; UK Government:
London, UK, 2013.
76. McDermott, L.; The eCRT Research Team; Yardley, L.; Little, P.; Ashworth, M.; Gulliford, M. Developing a computer delivered,
theory based intervention for guideline implementation in general practice. BMC Fam. Pr. 2010, 11, 90. [CrossRef] [PubMed]
77. LogMeIn. GoToMeeting Software Online Platform. 2017. Available online: https://www.logmeininc.com/about-us (accessed on
6 October 2017).
78. Sadasivam, R.S.; DeLaughter, K.; Crenshaw, K.; Sobko, H.J.; Williams, J.H.; Coley, H.L.; Ray, M.N.; Ford, D.E.; Allison, J.J.;
Houston, T.K.; et al. Development of an Interactive, Web-Delivered System to Increase Provider–Patient Engagement in Smoking
Cessation. J. Med. Internet Res. 2011, 13, e87. [CrossRef] [PubMed]
79. Vaismoradi, M.; Jones, J.; Turunen, H.; Snelgrove, S. Theme development in qualitative content analysis and thematic analysis. J.
Nurs. Educ. Pr. 2015, 6, 100. [CrossRef]
80. Burn, J.; Gerdes, A.-M.; Macrae, F.; Mecklin, J.-P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, D.G.; Maher, E.R.;
Bertario, L.; et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the
CAPP2 randomised controlled trial. Lancet 2011, 378, 2081–2087. [CrossRef]
81. Ouakrim, D.A.; Dashti, S.G.; Chau, R.; Buchanan, D.D.; Clendenning, M.; Rosty, C.; Winship, I.M.; Young, J.P.; Giles, G.;
Leggett, B.; et al. Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome. J. Natl. Cancer Inst. 2015, 107.
[CrossRef]
82. Otten, E.; Plantinga, M.; Birnie, E.; Verkerk, M.A.; Lucassen, A.M.; Ranchor, A.V.; Van Langen, I.M. Is there a duty to recontact in
light of new genetic technologies? A systematic review of the literature. Genet. Med. 2014, 17, 668–678. [CrossRef] [PubMed]
83. Nazi, K.M. The Personal Health Record Paradox: Health Care Professionals’ Perspectives and the Information Ecology of Personal
Health Record Systems in Organizational and Clinical Settings. J. Med. Internet Res. 2013, 15, e70. [CrossRef] [PubMed]
84. Pentz, R.D.; Peterson, S.K.; Watts, B.; Vernon, S.W.; Lynch, P.M.; Koehly, L.M.; Gritz, E.R. Hereditary Nonpolyposis Colorectal
Cancer Family Members’ Perceptions about the Duty to Inform and Health Professionals’ Role in Disseminating Genetic
Information. Genet. Test. 2005, 9, 261–268. [CrossRef]
85. Gorrie, A.; Archibald, A.D.; Ioannou, L.; Curnow, L.; McClaren, B. Exploring approaches to facilitate family communication of
genetic risk information after cystic fibrosis population carrier screening. J. Community Genet. 2018, 9, 71–80. [CrossRef]
86. Sustersic, M.; Gauchet, A.; Foote, A.; Bosson, J.-L. How best to use and evaluate Patient Information Leaflets given during a
consultation: A systematic review of literature reviews. Heal. Expect. 2016, 20, 531–542. [CrossRef]
87. Dilzell, K.; Kingham, K.; Ormond, K.; Ladabaum, U. Evaluating the utilization of educational materials in communicating about
Lynch syndrome to at-risk relatives. Fam. Cancer 2014, 13, 381–389. [CrossRef]
88. Metcalfe, A.; Plumridge, G.; Coad, J.; Shanks, A.; Gill, P. Parents’ and children’s communication about genetic risk: A qualitative
study, learning from families’ experiences. Eur. J. Hum. Genet. 2011, 19, 640–646. [CrossRef] [PubMed]
89. McAllister, M. Predictive Genetic Testing and Beyond: A Theory of Engagement. J. Heal. Psychol. 2002, 7, 491–508. [CrossRef]
90. Lafreniere, D.; Bouchard, K.; Godard, B.; Simard, J.; Dorval, M. Family communication following BRCA1/2 genetic testing: A
close look at the process. J. Genet. Couns. 2013, 22, 323–335. [CrossRef] [PubMed]
Cancers 2021, 13, 2404 22 of 22
91. Koehly, L.M.; Peters, J.A.; Kenen, R.; Hoskins, L.M.; Ersig, A.L.; Kuhn, N.R.; Loud, J.T.; Greene, M.H. Characteristics of Health
Information Gatherers, Disseminators, and Blockers Within Families at Risk of Hereditary Cancer: Implications for Family Health
Communication Interventions. Am. J. Public Heal. 2009, 99, 2203–2209. [CrossRef] [PubMed]
92. Rosenstock, I.M. Why People Use Health Services. Milbank Q. 2005, 83. [CrossRef]
93. Stoffel, E.M.; Murphy, C.C. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young
Adults. Gastroenterol. 2020, 158, 341–353. [CrossRef]
94. Heinlen, C.; Hovick, S.R.; Brock, G.N.; Klamer, B.G.; Toland, A.E.; Senter, L. Exploring genetic counselors’ perceptions of
usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM). J. Genet.
Couns. 2019, 28, 664–672. [CrossRef] [PubMed]
95. Mendes, Á.; Metcalfe, A.; Paneque, M.; Sousa, L.; Clarke, A.J.; Sequeiros, J. Communication of Information about Genetic Risks:
Putting Families at the Center. Fam. Process. 2017, 57, 836–846. [CrossRef]
96. Suthers, G.K.; Armstrong, J.; McCormack, J.; Trott, D. Letting the family know: Balancing ethics and effectiveness when notifying
relatives about genetic testing for a familial disorder. J. Med. Genet. 2006, 43, 665–670. [CrossRef]
97. Aktan-Collan, K.; Haukkala, A.; Pylvanainen, K.; Jarvinen, H.J.; Aaltonen, L.A.; Peltomaki, P.; Rantanen, E.; Kaariainen, H.;
Mecklin, J.-P. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA
testing. J. Med. Genet. 2007, 44, 732–738. [CrossRef]
98. Safarova, M.S.; Kullo, I.J. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology. Circ. Res.
2018, 122, 26–27. [CrossRef] [PubMed]
99. Bental, D.S.; Cawsey, A.; Jones, R. Patient information systems that tailor to the individual. Patient Educ. Couns. 1999, 36, 171–180.
[CrossRef]
100. Jacobs, R.J.; Lou, J.Q.; Ownby, R.L.; Caballero, J. A systematic review of eHealth interventions to improve health literacy. Heal.
Inform. J. 2014, 22, 81–98. [CrossRef] [PubMed]
101. Neuhauser, L.; Kreps, G.L. Online cancer communication: Meeting the literacy, cultural and linguistic needs of diverse audiences.
Patient Educ. Couns. 2008, 71, 365–377. [CrossRef]
102. Norman, M.L.; Malcolmson, J.; Armel, S.R.; Gillies, B.; Ou, B.; Thain, E.; McCuaig, J.M.; Kim, R.H. Stay at home: Implementation
and impact of virtualising cancer genetic services during COVID-19. J. Med. Genet. 2020. [CrossRef] [PubMed]
103. Williams, J.L.; Rahm, A.K.; Zallen, D.T.; Stuckey, H.; Fultz, K.; Fan, A.L.; Bonhag, M.; Feldman, L.; Segal, M.M.; Williams, M.S.
Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication. J.
Genet. Couns. 2018, 27, 358–369. [CrossRef] [PubMed]
104. Clipper, B. The Influence of the COVID-19 Pandemic on Technology: Adoption in Health Care. Nurse Lead. 2020, 18, 500–503.
[CrossRef] [PubMed]
